Harnessing Technology to Improve Clinical Trials: Study of Real-Time Informatics to Collect Data, Toxicities, Image Response Assessments, and Patient-Reported Outcomes in a Phase I... von PIETANZA, M. Catherine, BASCH, Ethan M, GABOW, Aaron, LATIF, Marcia, LIN, Kai-Hsiung, QINFEI WU, KASS, Samantha L, MILLER, Claire P, TYSON, Leslie, SUMNER, Dyana K, BERKOWITZ-HERGIANTO, Alison, SIMA, Camelia S, LASH, Alex, KRIS, Mark G, SCHWARTZ, Lawrence H, GINSBERG, Michelle S, BINSHENG ZHAO, SHOUERY, Marwan, SHAW, Mary, ROGAK, Lauren J, WILSON, Manda

Volltext

Phase II Trial of Temozolomide in Patients with Relapsed Sensitive or Refractory Small Cell Lung Cancer, with Assessment of Methylguanine-DNA Methyltransferase as a Potential Bioma... von CATHERINE PIETANZA, M, KADOTA, Kyuichi, CHAN, Timothy A, RIZVI, Naiyer A, AZZOLI, Christopher G, RIELY, Gregory J, KRIS, Mark G, KRUG, Lee M, HUBERMAN, Kety, SIMA, Camelia S, FIORE, John J, SUMNER, Dyana K, TRAVIS, William D, HEGUY, Adriana, GINSBERG, Michelle S, HOLODNY, Andrei I

Volltext

Trial of a 5-day dosing regimen of temozolomide in patients with relapsed small cell lung cancers with assessment of methylguanine-DNA methyltransferase von Zauderer, Marjorie G, Drilon, Alex, Kadota, Kyuichi, Huberman, Kety, Sima, Camelia S, Bergagnini, Isabella, Sumner, Dyana K, Travis, William D, Heguy, Adriana, Ginsberg, Michelle S, Holodny, Andrei I, Riely, Gregory J, Kris, Mark G, Krug, Lee M, Pietanza, M. Catherine

Volltext

Real-time informatics to collect data, toxicities, image response assessments, and patient-reported outcomes (PROs) in a phase II clinical trial von Pietanza, Maria Catherine, Basch, Ethan M., Lash, Alex, Schwartz, Lawrence H., Ginsberg, Michelle S., Zhao, Binsheng, Shouery, Marwan, Shaw, Mary, Rogak, Lauren J., Wilson, Manda, Gabow, Aaron, Latif, Marcia, Wu, Quinfei, Kass, Samantha Lindsay, Miller, Claire, Tyson, Leslie B., Sumner, Dyana K., Berkowitz, Alison, Sima, Camelia S., Kris, Mark G.

Volltext

5-day dosing schedule of temozolomide in relapsed sensitive or refractory small cell lung cancer (SCLC) and methyl-guanine-DNA methyltransferase (MGMT) analysis in a phase II trial von Drilon, Alexander Edward Dela Cruz, Kyuichi, Kadota, Huberman, Kety H, Sima, Camelia S., Fiore, John Joseph, Yu, Helena Alexandra, Varghese, Anna M., Sumner, Dyana K., Travis, William D, Heguy, Adriana, Ginsberg, Michelle S., Holodny, Andrei, Chan, Timothy An-thy, Rizvi, Naiyer A., Azzoli, Christopher G., Riely, Gregory J., Kris, Mark G., Krug, Lee M., Pietanza, Maria Catherine

Volltext